Abuse-deterrent opioid formulations have not yet been widely accepted despite their proposed value in reducing opioid abuse and related mortality. Many of the current barriers to broader use are related to their higher cost compared with conventional formulations.
Research has been insufficient to elucidate the prevalence, course, and clinical correlates of rapid cycling in bipolar disorder.
Comorbid depression, when not well controlled, can affect one’s ability to self-manage diabetes. There can be loss of interest in making proper lifestyle choices, monitoring glucose levels, and taking one’s medicines.
There are a number of very plausible hypotheses of what it is about childbirth that is such a potent trigger for severe postpartum episodes in women with bipolar disorder.
An AAEP task force created recommendations for medical evaluation of psychiatric patients presenting to the ED.
New findings suggest that DSM-5 criteria may apply to betel use disorder and offer opportunities to advance the study and understanding of substance use disorder in general.
Increased implementation of integrated primary care could help to improve the availability of psychological treatment for this patient population.
Rheuatology Advisor speaks with a psychologist about addressing mental health in patients with inflammatory arthritis.
It has been proposed that inflammation stemming from persistent pathogens may influence the development of mood disorders.
Endocrinologist Kevin M. Pantalone, DO, and psychiatrist Christian Kohler, MD, discuss the risk associated with the use of antipsychotic medications in individuals with type 2 diabetes.
